Endari Will Be a New Specialty Med for Sickle Cell Disease

Endari (en-DAR-ee, L-glutamine) is the first sickle cell treatment to be approved in almost 20 years....

Exclusive Subscriber Content

  • Best in class medication learning
  • Concise recommendations
  • Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login